The RATIO Registry: French Registry on Opportunistic and Severe Bacterial Infections and Lymphoma in Patients Treated With TNF-a Antagonists
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Rheumatoid Arthritis, Crohn's Disease, Ankylosing Spondylitis, Psoriasis
Both
Rheumatoid Arthritis, Crohn's Disease, Ankylosing Spondylitis, Psoriasis
Trial Information
The RATIO Registry: French Registry on Opportunistic and Severe Bacterial Infections and Lymphoma in Patients Treated With TNF-a Antagonists
Inclusion Criteria
Inclusion Criteria for cases:
- past or current treatement with TNF-a antagonists
- either lymphoma severe bacterial infection opportunistic infection
Inclusion Criteria for controls:
- matched with cases by gender, age (+/- 5 years), underlying disease (rheumatoid
arthritis, ankylosing spondylitis, Crohn's disease, or psoriasis)
- past or current treatement with TNF-a antagonists
- no lymphoma, severe bacterial infection, opportunistic infection (same as case)
Exclusion Criteria:
- none
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Observational Model: Natural History, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Xavier Mariette, MD PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistance Publique - Hôpitaux de Paris
Authority:
France: Ministry of Health
Study ID:
1
NCT ID:
NCT00224562
Start Date:
February 2004
Completion Date:
Related Keywords:
- Rheumatoid Arthritis
- Crohn's Disease
- Ankylosing Spondylitis
- Psoriasis
- TNF alpha antagonists
- infections
- lymphoma
- safety
- Arthritis
- Arthritis, Rheumatoid
- Crohn Disease
- Lymphoma
- Psoriasis
- Spondylitis
- Spondylitis, Ankylosing
Name | Location |
|---|
